Outset Medical, Inc. Cash Flow Statement
OM|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
Outset Medical, Inc. used $131M in operating cash flow and negative free cash flow of $135M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | -$172.8M | -$163.0M | -$131.9M | -$121.5M | -$68.3M | -$49.8M |
| Depreciation & Amortization | $5.8M | $5.2M | $5.2M | $3.2M | $1.5M | $1.1M |
| Operating Cash Flow | -$131.4M | -$145.7M | -$130.3M | -$99.0M | -$70.3M | -$46.4M |
| Capital Expenditures | $3.4M | $8.3M | $3.1M | $9.1M | $3.3M | $1.8M |
| Free Cash Flow | -$134.8M | -$154.1M | -$133.4M | -$108.1M | -$73.6M | -$48.2M |
| FCF Margin | -103.4% | -133.5% | -130.0% | -216.5% | -488.0% | -2402.0% |